NAVLE Nervous

Camelidae and Cervidae Tetanus Study Guide

Tetanus is a potentially fatal neurological disease caused by the neurotoxin tetanospasmin produced by Clostridium tetani, an anaerobic, spore-forming, gram-positive bacillus.

Overview and Clinical Importance

Tetanus is a potentially fatal neurological disease caused by the neurotoxin tetanospasmin produced by Clostridium tetani, an anaerobic, spore-forming, gram-positive bacillus. While tetanus is relatively uncommon in camelids and cervids compared to horses, these species remain susceptible and cases are reported in veterinary literature. Understanding the pathophysiology, clinical presentation, and management of tetanus is essential for NAVLE success and clinical practice.

Camelids (llamas, alpacas, guanacos, vicunas) and cervids (deer, elk, reindeer, moose) represent expanding sectors of veterinary practice in North America and Europe. Tetanus in these species often follows wounds from castration, shearing, antler trauma, or environmental injuries. Early recognition and aggressive treatment are critical for survival.

Characteristic Description
Morphology Gram-positive rod (0.3-0.6 μm × 3-12 μm); terminal spherical spores create "drumstick" or "tennis racket" appearance
Oxygen Requirements Obligate anaerobe - cannot survive in presence of oxygen
Spore Resistance Extremely heat-resistant; survive boiling for 10-15 min (some strains up to 3 hours); killed by autoclaving at 121°C for 20 min
Toxins Produced Tetanospasmin (neurotoxin) and tetanolysin (hemolysin)
Environmental Survival Spores survive years in soil; resistant to most antiseptics; killed by iodine, hydrogen peroxide, glutaraldehyde

Etiology

Causative Agent

Clostridium tetani is an obligate anaerobic, gram-positive, spore-forming bacillus. The organism is ubiquitous in the environment, found in soil (especially cultivated soil), dust, and the gastrointestinal tract of many animals including horses, cattle, sheep, and humans.

Organism Characteristics

High-YieldTetanospasmin is one of the most potent toxins known - the estimated lethal dose for humans is approximately 2.5 ng/kg body weight. Only botulinum toxin is more potent.
Species Susceptibility Clinical Notes
Horses HIGHLY susceptible Most sensitive domestic species; 80% mortality rate; vaccination is CORE
Sheep/Lambs HIGHLY susceptible Risk after docking, castration with bands; vaccination common
Camelids Moderately susceptible Not highly susceptible but cases reported; vaccination included in CD-T protocols
Cervids Moderately susceptible Sporadic cases; risk with antler trauma, wound contamination; 80% mortality in reindeer
Cattle More resistant Less commonly affected; better prognosis than horses
Dogs/Cats Relatively resistant Localized tetanus common; 50-90% survival; vaccination NOT recommended
Birds Highly resistant Lethal dose 10,000-300,000× greater than horses (per kg)

Pathophysiology

Mechanism of Tetanospasmin

The pathogenesis of tetanus involves a precise sequence of events from wound contamination to neurotoxic effects. Understanding this mechanism is essential for NAVLE questions on tetanus.

Step-by-Step Pathogenesis

  • Wound Contamination: C. tetani spores enter through deep puncture wounds, surgical sites (castration, dehorning), or umbilical stumps (neonates). Anaerobic conditions in necrotic tissue allow spore germination.
  • Toxin Production: Vegetative bacteria remain localized at the wound site and produce tetanospasmin, which is released upon bacterial autolysis. The bacteria do NOT spread systemically.
  • Toxin Binding: Tetanospasmin (150 kDa protein with heavy and light chains) binds to ganglioside receptors (GT1b) on presynaptic terminals of motor neurons at neuromuscular junctions.
  • Retrograde Axonal Transport: The toxin is internalized and transported retrograde along motor neuron axons to the spinal cord and brainstem (rate: approximately 75-250 mm/day).
  • Trans-synaptic Movement: Toxin crosses synapses to reach inhibitory interneurons (Renshaw cells and GABAergic/glycinergic neurons).
  • SNARE Protein Cleavage: The light chain (zinc-dependent metalloprotease) cleaves synaptobrevin (VAMP), preventing vesicular release of inhibitory neurotransmitters GABA and glycine.
  • Disinhibition: Loss of inhibitory input results in unopposed excitatory stimulation of alpha motor neurons, causing sustained muscle contraction (spastic paralysis).
Form Description Prognosis
Generalized (80%) Most common; descending pattern from jaw to body; affects entire body Poor to guarded; mortality up to 80% in horses
Localized Muscle stiffness confined to area near wound; may progress to generalized Better; about 1% mortality
Cephalic Follows head wounds; cranial nerve involvement; may cause facial paralysis initially Poor; 15-30% mortality; often progresses
Neonatal Umbilical stump infection in neonates; poor hygiene at delivery Very poor; high mortality

Species Susceptibility

Comparative Species Sensitivity

Diagnostic Method Findings/Limitations
History Recent wound, castration, shearing, antler trauma, surgical procedure within past 1-30 days
Physical Examination Characteristic posture, trismus, prolapsed third eyelid, hyperesthesia; may identify wound
Wound Culture C. tetani isolated in only 30% of cases; negative culture does NOT rule out tetanus
CSF Analysis Usually NORMAL in tetanus; helps rule out meningitis, encephalitis
Serum CK May be elevated due to sustained muscle contraction; nonspecific
Mouse Bioassay Injection of wound exudate into mice causes tetanic spasms if toxin present; rarely performed

Clinical Signs

Incubation Period

The incubation period typically ranges from 3 days to 3 weeks (average 10-14 days), but can extend to several months if spores remain dormant before germinating. A shorter incubation period generally indicates more severe disease and worse prognosis.

Forms of Tetanus

Classic Clinical Signs in Camelids and Cervids

Early Signs

  • Trismus (lockjaw): Difficulty opening mouth due to masseter muscle spasm - often first sign recognized
  • Stiff gait: Progressive stiffness in limbs; animal may walk like a "sawhorse"
  • Extended neck: Neck held rigidly extended; reluctance to lower head
  • Third eyelid prolapse: Visible protrusion/flashing of nictitating membrane, especially when startled

Progressive Signs

  • Risus sardonicus: Facial muscle spasm creating grimace/sardonic grin with retracted lips
  • Erect ears: Ears held rigidly erect and forward
  • Dysphagia: Difficulty swallowing; may drool saliva or regurgitate
  • Tail elevation: "Pump-handle" tail position; held stiffly elevated

Severe/Terminal Signs

  • Opisthotonus: Severe arching of head, neck, and back due to extensor muscle predominance
  • Tetanic spasms: Violent muscle contractions triggered by noise, light, or touch; can cause fractures
  • Recumbency: Inability to stand; once recumbent, prognosis is grave
  • Respiratory compromise: Diaphragm and intercostal muscle spasm leading to respiratory failure
  • Autonomic dysfunction: Tachycardia, hypertension alternating with hypotension, hyperthermia, sweating
NAVLE TipThe classic tetanus triad for board exams: (1) History of wound/procedure, (2) Muscle stiffness progressing to spasms, (3) Normal mentation (animal is ALERT but cannot move). This distinguishes tetanus from encephalitic conditions where mentation is altered.
Condition Distinguishing Features
Strychnine Poisoning More pronounced intermittent spasms with relaxation between episodes; earlier death; history of exposure
Meningitis Altered mentation, fever, abnormal CSF (increased protein, pleocytosis)
Rabies Behavioral changes, aggression or paralytic form, progressive; altered mentation
Listeriosis Circling, cranial nerve deficits, head tilt; altered mentation
Hypocalcemia May cause spasms but autonomic signs absent; responds to calcium
Parelaphostrongylus tenuis Camelid-specific; ataxia, paresis; CSF eosinophilia; asymmetric signs

Diagnosis

Diagnosis of tetanus is primarily clinical, based on characteristic history and clinical signs. Laboratory confirmation is often unreliable and should not delay treatment.

Diagnostic Approach

Differential Diagnosis

Treatment Goal Agent/Intervention Dosage/Notes
Eliminate Bacteria Metronidazole (preferred) 15-25 mg/kg PO or IV q8-12h for 7-10 days
Penicillin G (alternative) 22,000-44,000 IU/kg IM or IV q6-12h for 7-10 days
Neutralize Toxin Tetanus Antitoxin (TAT) Camelids/cervids: 3,000-15,000 IU IM/SC; repeat in 7 days if needed; give BEFORE wound debridement
Control Spasms Diazepam 0.1-0.5 mg/kg IV slowly; repeat PRN or continuous infusion
Chlorpromazine 0.2-0.4 mg/kg IM q6-12h
Magnesium sulfate 50 mg/kg/hour IV infusion; monitor for hypotension
Wound Management Debridement and lavage After antitoxin administration; remove necrotic tissue; flush with oxidizing agents
Supportive Care Dark, quiet environment Minimize stimuli that trigger spasms (noise, light, touch)
Fluid therapy IV fluids to maintain hydration; may need feeding tube if dysphagia
Deep bedding/padding Prevent decubital ulcers; slings may help ambulatory animals
Active Immunization Tetanus Toxoid Give at different site from antitoxin; repeat in 4-6 weeks

Treatment

Treatment of tetanus requires a multimodal approach targeting: (1) elimination of C. tetani, (2) neutralization of unbound toxin, (3) control of muscle spasms, and (4) supportive care. Treatment should begin immediately upon clinical suspicion.

Treatment Protocol Summary

High-YieldMetronidazole is preferred over penicillin for tetanus treatment. While both are effective against C. tetani, penicillin is a known GABA antagonist and theoretically could worsen muscle rigidity. Studies show lower mortality with metronidazole.

CRITICAL: Tetanus antitoxin only neutralizes UNBOUND circulating toxin. Once toxin binds to nerve endings, it cannot be reversed. This is why symptoms may progress even after antitoxin administration. Early treatment is essential!

Prognostic Factor Impact
Incubation period less than 7 days POOR - rapid progression indicates high toxin load
Recumbency GRAVE - especially if animal cannot rise
Respiratory compromise GRAVE - respiratory failure is leading cause of death
Ambulatory at presentation FAIR - if animal can stand, prognosis is better
Localized tetanus GOOD - approximately 99% survival if remains localized
Recovery timeline Survivors: 2-6 weeks for improvement; months for full recovery

Prognosis

Prognosis depends on species, severity of disease at presentation, and speed of treatment initiation.

Category Vaccination Protocol
Naive Adults Initial series: 2 doses of CD-T, 3-6 weeks apart; then annual boosters
Crias/Fawns Begin at 4-8 weeks; 2-3 dose series; boosters annually; may give antitoxin at birth in high-risk areas
Pregnant Females Booster 4-6 weeks before parturition for colostral antibody transfer
Wound Management If greater than 6 months since vaccination: give booster + antitoxin (different sites)
Unvaccinated with Wound Antitoxin 1,500-3,000 IU immediately + begin toxoid series (different sites)

Prevention and Vaccination

Vaccination Protocols

Tetanus is highly preventable through vaccination. In camelids, tetanus toxoid is typically included in combination vaccines with Clostridium perfringens types C and D (CD-T vaccine).

Additional Prevention Measures

  • Maintain clean pastures free of sharp objects, nails, wire
  • Use aseptic technique for castration, shearing, and other procedures
  • Prompt wound care: clean thoroughly, debride necrotic tissue
  • Use oxidizing disinfectants (iodine, chlorine compounds) that kill spores
  • Recovered animals should be vaccinated - tetanus does NOT confer natural immunity

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →